Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis

Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD–MBD is very important in the clinic. In China, Fucoidan (FPS), a natural compound of Laminaria japoni...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Liu, Bu-Hui, Chong, Fee-Lan, Yuan, Can-Can, Liu, Ying-Lu, Yang, Hai-Ming, Wang, Wen-Wen, Fang, Qi-Jun, Wu, Wei, Wang, Mei-Zi, Tu, Yue, Wan, Zi-Yue, Wan, Yi-Gang, Wu, Guo-Wen
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941278/
https://ncbi.nlm.nih.gov/pubmed/33708111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.586725
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki